| scholarly article | Q13442814 |
| P50 | author | Markku Mäki | Q16989186 |
| Pekka Collin | Q89848105 | ||
| Katri Kaukinen | Q102075472 | ||
| Tuuli Välineva | Q125194634 | ||
| Merja Ashorn | Q125195048 | ||
| Sari Iltanen | Q125195060 | ||
| Sara Ashorn | Q125195109 | ||
| Hanna Raukola | Q125195230 | ||
| Tiina Luukkaala | Q57079740 | ||
| P2093 | author name string | Jonathan Braun | |
| Bo Wei | |||
| Immo Rantala | |||
| P2860 | cites work | ??? | Q28303013 |
| Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. | Q64966964 | ||
| Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition | Q68541043 | ||
| Morphometric study of the jejunal mucosa in various childhood enteropathies with special reference to intraepithelial lymphocytes | Q70638095 | ||
| Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease | Q73697845 | ||
| IgA- and IgG-class antihuman umbilical cord antibody tests in adult coeliac disease | Q74456814 | ||
| IgA antibodies to tissue transglutaminase: An effective diagnostic test for celiac disease | Q77946821 | ||
| Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease | Q78442475 | ||
| Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? | Q79871772 | ||
| Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease | Q80211813 | ||
| A comprehensive screen for SNP associations on chromosome region 5q31-33 in Swedish/Norwegian celiac disease families | Q80434469 | ||
| Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype | Q81077325 | ||
| Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet | Q81632269 | ||
| Altered expression, localization, and phosphorylation of epithelial junctional proteins in celiac disease | Q83180909 | ||
| Elevated serum anti-I2 and anti-OmpW antibody levels in children with IBD | Q83276936 | ||
| New serological markers in inflammatory bowel disease are associated with complicated disease behaviour | Q22242048 | ||
| Molecular evidence for Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn's disease correlates with enhanced TNF-α secretion | Q22252236 | ||
| Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance | Q24540422 | ||
| Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls | Q24550675 | ||
| Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease | Q24675623 | ||
| Identification of tissue transglutaminase as the autoantigen of celiac disease | Q28243044 | ||
| Genetics of inflammatory bowel disease: the role of the HLA complex | Q28245979 | ||
| Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue') | Q28286857 | ||
| Anti-Saccharomyces cerevisiae antibodies in coeliac disease | Q28305627 | ||
| Ecological and evolutionary forces shaping microbial diversity in the human intestine | Q29547586 | ||
| Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. | Q32099571 | ||
| Molecular cloning of a Bacteroides caccae TonB-linked outer membrane protein identified by an inflammatory bowel disease marker antibody | Q34009198 | ||
| Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease | Q34392575 | ||
| The anti-Saccharomyces cerevisiae antibody assay in a province-wide practice: accurate in identifying cases of Crohn's disease and predicting inflammatory disease | Q34474950 | ||
| Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines | Q34566764 | ||
| Clustering of increased small intestinal permeability in families with Crohn's disease. | Q34742820 | ||
| Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease | Q35358278 | ||
| Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics | Q35361496 | ||
| Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. | Q35598393 | ||
| Normal small bowel biopsy followed by coeliac disease | Q35625231 | ||
| Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression | Q36484765 | ||
| Induction of mucosal immune responses by bacteria and bacterial components. | Q41451922 | ||
| Identification of a novel bacterial sequence associated with Crohn's disease | Q41746274 | ||
| Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease | Q41965718 | ||
| Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. | Q42844034 | ||
| Missing endomysial and reticulin binding of coeliac antibodies in transglutaminase 2 knockout tissues | Q43003801 | ||
| Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens | Q46134666 | ||
| Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease | Q47220054 | ||
| Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. | Q47676140 | ||
| Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. | Q52565792 | ||
| Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. | Q54443565 | ||
| Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet | Q57000152 | ||
| Incrimination of anaerobic bacteria in the induction of experimental colitis | Q57241209 | ||
| Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease | Q57606857 | ||
| P433 | issue | 5 | |
| P921 | main subject | antibody | Q79460 |
| Saccharomyces cerevisiae | Q719725 | ||
| P304 | page(s) | 486-494 | |
| P577 | publication date | 2008-05-22 | |
| P1433 | published in | Journal of Clinical Immunology | Q6294961 |
| P1476 | title | Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease | |
| P478 | volume | 28 |
| Q40301248 | A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice. |
| Q37324629 | Advances in epidemiology and diagnosis of inflammatory bowel diseases |
| Q37316825 | Anti-microbial antibodies in celiac disease: trick or treat? |
| Q33696823 | Celiac disease |
| Q38072225 | Circulating antibodies against bacterial wall products: are there arguments for early immunosuppression? |
| Q64245479 | D-methionine alleviates cisplatin-induced mucositis by restoring the gut microbiota structure and improving intestinal inflammation |
| Q33848148 | Early microbial markers of celiac disease |
| Q33489534 | Host responses to intestinal microbial antigens in gluten-sensitive mice |
| Q36426072 | Increased bacterial translocation in gluten-sensitive mice is independent of small intestinal paracellular permeability defect |
| Q42099739 | Long term diarrhoea caused by simultaneous Crohn's disease and coeliac disease in the same patient |
| Q60960104 | Microbial Transglutaminase Is Immunogenic and Potentially Pathogenic in Pediatric Celiac Disease |
| Q27011525 | Microbiology, genomics, and clinical significance of the Pseudomonas fluorescens species complex, an unappreciated colonizer of humans |
| Q37898405 | Nutritional influences in selected gastrointestinal diseases |
| Q37937183 | Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease |
| Q37829904 | Serologic antiglycan antibodies in inflammatory bowel disease. |
| Q37164024 | Serological responses to microbial antigens in celiac disease patients during a gluten-free diet |
| Q92229947 | T cell receptor cross-reactivity between gliadin and bacterial peptides in celiac disease |
| Q57030425 | The Effect of Gluten-Free Diet on Health and the Gut Microbiota Cannot Be Extrapolated from One Population to Others |
Search more.